Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000626219 | SCV000746864 | pathogenic | Kabuki syndrome 1 | 2017-12-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001388480 | SCV001589479 | pathogenic | Kabuki syndrome | 2022-12-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr4606*) in the KMT2D gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KMT2D are known to be pathogenic (PMID: 22126750). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with KMT2D-related conditions. ClinVar contains an entry for this variant (Variation ID: 523017). For these reasons, this variant has been classified as Pathogenic. |